BioNTech SE
Price Action
Technical Summary
DOWNTRENDBioNTech SE is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 35), showing significant lag compared to the market leaders. Earnings contraction of 214% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $101.02 | -5.70% | BELOW |
| 50 SMA | $96.83 | -1.62% | BELOW |
| 100 SMA | $100.56 | -5.27% | BELOW |
| 150 SMA | $101.27 | -5.93% | BELOW |
| 200 SMA | $102.41 | -6.99% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BNTX in an uptrend right now?
BNTX has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is BNTX overbought or oversold?
BNTX's RSI (14) is 44. The stock is in neutral territory, neither overbought nor oversold.
Is BNTX outperforming the market?
BNTX has a Relative Strength (RS) Rating of 35 out of 99. BNTX is currently lagging the broader market.
Where is BNTX in its 52-week range?
BNTX is trading at $95.26, which is 77% of its 52-week high ($124.00) and 35% above its 52-week low ($79.52).
How volatile is BNTX?
BNTX has a Beta of 1.14 and 52-week volatility of 46%. It's more volatile than the S&P 500 - expect bigger swings.